https://mavengity.com/articles/finance/zoe-financial-adviser-referral-algorithm-settlement/ Mavengity en 2026-09-28T23:46:39+02:00 The SEC Fined Zoe Financial Over Who Really Picked Its Clients' Advisers https://mavengity.com/articles/legal/alito-recusal-suncor-boulder-climate-case/ Mavengity en 2026-09-28T22:46:10+02:00 Alito Steps Out of the Climate Case and Says Nothing About Why https://mavengity.com/articles/legal/florida-openai-temporary-injunction-model-guardrails/ Mavengity en 2026-09-28T18:48:22+02:00 Florida Asks a Court to Bar New OpenAI Models Without Outside Safety Approval https://mavengity.com/articles/finance/opportunity-zone-fund-reporting-rule-penalty/ Mavengity en 2026-09-28T16:11:05+02:00 The IRS Proposed a Reporting Rule for Opportunity Funds, With a $500-a-Day Penalty Attached https://mavengity.com/articles/finance/italy-fuel-price-cap-eni-wholesale-gap/ Mavengity en 2026-09-28T16:03:25+02:00 Eni Capped Its Own Pump Prices. Italy's Fuel Problem Sits Upstream. https://mavengity.com/articles/healthcare-medical/tavapadon-parkinsons-approval-discontinuation-rate/ Mavengity en 2026-09-28T15:57:35+02:00 A New Parkinson's Drug Lifted Motor Scores, and 38 Percent of Trial Patients Stopped Taking It https://mavengity.com/articles/legal/openai-training-pause-agent-incidents-no-statute/ Mavengity en 2026-09-28T15:51:01+02:00 OpenAI Paused Training, and No Statute Told It To https://mavengity.com/articles/healthcare-medical/federal-corporate-medicine-ban-targets-management-contract/ Mavengity en 2026-09-28T13:53:47+02:00 A Federal Corporate Medicine Ban Targets the Management Contract https://mavengity.com/articles/legal/fifty-desegregation-cases-end-unitary-status-standard/ Mavengity en 2026-09-28T13:51:52+02:00 Fifty Desegregation Cases End, and Each One Still Needed a Judge https://mavengity.com/articles/finance/atm-surcharge-settlement-refunds-network-set-fee/ Mavengity en 2026-09-28T13:48:02+02:00 The ATM Surcharge Settlement Refunds Nineteen Years of a Fee the Networks Set